Molecular Targets of Diabetic Cardiovascular Complications

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|6|4|487-494

ISSN： 1389-4501

Source： Current Drug Targets, Vol.6, Iss.4, 2005-06, pp. : 487-494

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Targets of Diabetic Vascular Complications and Potential New Drugs

By  

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 503-509

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative Effects of Garlic and Aspirin on Diabetic Cardiovascular Complications

By Patumraj S.   Tewit S.   Amatyakul S.   Jariyapongskul A.   Maneesri S.   Kasantikul V.   Shepro D.  

Drug Delivery, Vol. 7, Iss. 2, 2000-04 ,pp. : 91-96

Informa Healthcare

Access to resources Recommend Favorite

Role of Antioxidants in Redox Regulation of Diabetic Cardiovascular Complications

By  

Current Pharmaceutical Biotechnology, Vol. 11, Iss. 8, 2010-12 ,pp. : 819-836

Bentham Science Publishers

Access to resources Recommend Favorite

LOX-1, Oxidative Stress and Inflammation: A Novel Mechanism for Diabetic Cardiovascular Complications

By Yan Meiling  

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 5, 2011-10 ,pp. : 451-459

Springer Publishing Company

Access to resources Recommend Favorite

Sufficient Weight Reduction Decreases Cardiovascular Complications in Diabetic Patients with the Metabolic Syndrome

By  

Heart Drug, Vol. 5, Iss. 2, 2005-03 ,pp. : 68-74

Karger

Access to resources Recommend Favorite